HuGE Literature Finder
Records
1
-
30
| Antiplatelet and myocardial protective effect of Shexiang Tongxin Dropping Pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of integrative medicine 2022 Jan . Lin Yan-Jun, Jiao Kun-Li, Liu Bo, Fang Lu, Meng S |
| Clopidogrel Use and CYP2C19 Genotypes in Patients Undergoing Vascular Intervention Procedure: A Hospital-Based Study. Pharmacogenomics and personalized medicine 2022 15 81-89. Liao Yi-Ju, Hsiao Tzu-Hung, Lin Ching-Heng, Hsu Chun-Sheng, Chang Yen-Lin, Chen Yu-Wei, Hsu Chiann-Yi, Chen Yi-Ming, Wu Ming-F |
| Clinical Outcomes after Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms. Journal of cardiovascular pharmacology 2021 Oct . Zhang Yang, Zhao Xiliang, Ye Yicong, Li Quan, Zeng Yo |
| Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients. International journal of cardiology 2021 Sep . Al-Rubaish Abdullah M, Al-Muhanna Fahad A, Alshehri Abdullah M, Al-Mansori Mohammed A, Alali Rudaynah A, Khalil Rania M, Al-Faraidy Khalid A, Cyrus Cyril, Sulieman Mohammed M, Vatte Chittibabu, Loza Bao-Li, Claassens Daniel M F, Asselbergs Folkert W, Al-Ali Amein |
| Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study. BMC cardiovascular disorders 2021 Aug 21 (1): 391. Yu Luhai, Wang Tingting, Bai Huidong, Zhu Weijiang, Li Yanju, Wu Jianhua, Liu Wenli, Sun Li, Yu Aiping, Li Hongji |
| Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients. International journal of cardiology 2021 Apr . Claassens Daniel M F, Gimbel Marieke E, Bergmeijer Thomas O, Vos Gerrit J A, Hermanides Renicus S, van der Harst Pim, Barbato Emanuele, Morisco Carmine, Tjon Joe Gin Richard M, de Vrey Evelyn A, Heestermans Ton A C M, Jukema J Wouter, von Birgelen Clemens, Waalewijn Reinier A, Hofma Sjoerd H, den Hartog Frank R, Voskuil Michiel, Van't Hof Arnoud W J, Asselbergs Folkert W, Mosterd A, Herrman Jean-Paul R, Dewilde Willem, Mahmoodi Bakhtawar K, Deneer Vera H M, Ten Berg Jurriën |
| Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y Inhibitor Therapy: A Meta-Analysis. JACC. Cardiovascular interventions 2021 Apr 14 (7): 739-750. Pereira Naveen L, Rihal Charanjit, Lennon Ryan, Marcus Gil, Shrivastava Sanskriti, Bell Malcolm R, So Derek, Geller Nancy, Goodman Shaun G, Hasan Ahmed, Lerman Amir, Rosenberg Yves, Bailey Kent, Murad M Hassan, Farkouh Michael |
| Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients. BMC neurology 2021 Mar 21 (1): 104. Li Changqing, Jia Weihua, Li Jian, Li Fangfei, Ma Jing, Zhou Lich |
| Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients. Aging 2021 Mar 13 (5): 6506-6524. Cha Jung-Joon, Park Jae Hyoung, Joo Hyung Joon, Hong Soon Jun, Ahn Tae Hoon, Kim Byeong-Keuk, Shin WonYong, Ahn Sung Gyun, Yoon JungHan, Kim Yong Hoon, Cho Yun-Hyeong, Kang Woong Chol, Kim Weon, Lim Young-Hyo, Gwon Hyeon Cheol, Choi Woong Gil, Lim Do-S |
| [Association of CYP2C19 and CYP3A5 gene polymorphisms with myocardial infarction]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2021 Jan 38 (1): 87-91. Qi Lin, Liang Wei, Qiao Hui, Wang Ruimin, Han Jingxian, Xing Xiaofei, Hu Yuw |
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium.
Clinical pharmacology and therapeutics 2020 May . Verma Shefali Setia, Bergmeijer Thomas O, Gong Li, Reny Jean-Luc, Lewis Joshua P, Mitchell Braxton D, Alexopoulos Dimitrios, Aradi Daniel, Altman Russ B, Bliden Kevin, Bradford Yuki, Campo Gianluca, Chang Kiyuk, Cleator John H, Déry Jean-Pierre, Dridi Nadia P, Fernandez-Cadenas Israel, Fontana Pierre, Gawaz Meinrad, Geisler Tobias, Gensini Gian Franco, Giusti Betti, Gurbel Paul A, Hochholzer Willibald, Holmvang Lene, Kim Eun-Young, Kim Ho-Sook, Marcucci Rossella, Montaner Joan, Backman Joshua D, Pakyz Ruth E, Roden Dan M, Schaeffeler Elke, Schwab Matthias, Shin Jae Gook, Siller-Matula Jolanta M, Ten Berg Jurriën M, Trenk Dietmar, Valgimigli Marco, Wallace John, Wen Ming-Shien, Kubo Michiaki, Lee Ming Ta Michael, Whaley Ryan, Winter Stefan, Klein Teri E, Shuldiner Alan R, Ritchie Marylyn D, |
| CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel- or ticagrelor-treated STEMI patients: monocentric study in PRAGUE-18 trial participants. Xenobiotica; the fate of foreign compounds in biological systems 2020 Feb 1-22. Máchal J, Hlinomaz O, Kostolanská K, Peš O, Máchalová A, Šplíchal Z, Motovská Z, Jurica |
| Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial. JAMA 2020 08 324 (8): 761-771. Pereira Naveen L, Farkouh Michael E, So Derek, Lennon Ryan, Geller Nancy, Mathew Verghese, Bell Malcolm, Bae Jang-Ho, Jeong Myung Ho, Chavez Ivan, Gordon Paul, Abbott J Dawn, Cagin Charles, Baudhuin Linnea, Fu Yi-Ping, Goodman Shaun G, Hasan Ahmed, Iturriaga Erin, Lerman Amir, Sidhu Mandeep, Tanguay Jean-Francois, Wang Liewei, Weinshilboum Richard, Welsh Robert, Rosenberg Yves, Bailey Kent, Rihal Charanj |
| Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction. The Indian journal of medical research 2019 Jul 150 (1): 50-61. Pandey Chandra Prakash, Misra Ankita, Negi Mahendra Pal Singh, Kanuri Babu Nageswararao, Chhonker Yashpal Singh, Bhatta Rabi Shanker, Narain Varun Shanker, Dikshit Mad |
| Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel. Circulation. Cardiovascular interventions 2019 May 12 (5): e007019. Xu Ke, Ye Sen, Zhang Shuhua, Yang Mingwen, Zhu Tiantian, Kong Deyu, Chen Jun, Xu Lei, Li Jimin, Zhu Hui, Wang Fei, Yang Lu, Zhang Jing, Fan Yuansheng, Ying Lianghong, Hu Xianqing, Zhang Xiaofeng, Chan Noel C, Li Chunji |
| CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis. Platelets 2019 30 (2): 229-240. Xi Ziwei, Fang Fang, Wang Jiayang, AlHelal Jumana, Zhou Yujie, Liu W |
| Tailored Adjunctive Cilostazol Therapy Based on CYP2C19 Genotyping in Patients With Acute Myocardial Infarction - The CALDERA-GENE Study. Circulation journal : official journal of the Japanese Circulation Society 2018 May . Kaikita Koichi, Yoshimura Hiromi, Ishii Masanobu, Kudoh Takashi, Yamada Yoshihiro, Yamamoto Eiichiro, Izumiya Yasuhiro, Kojima Sunao, Shimomura Hideki, Tsunoda Ryusuke, Matsui Kunihiko, Ogawa Hisao, Tsujita Kenichi, |
| Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China. European journal of clinical pharmacology 2018 Apr 74 (4): 423-431. Zhong Zhixiong, Hou Jingyuan, Zhang Qifeng, Li Bin, Li Cunren, Liu Zhidong, Yang Min, Zhong Wei, He Xuebo, Wu Hesen, Zhong Miaocai, Zhao Pings |
| The secondary prevention of stroke according to cytochrome P450 2C19 genotype in patients with acute large-artery atherosclerosis stroke. Oncotarget 2018 Apr 9 (25): 17725-17734. Yi Xingyang, Lin Jing, Zhou Ju, Wang Yanfeng, Huang Ruyue, Wang Ch |
| CYP2C19 Genotype is an Independent Predictor of Adverse Cardiovascular Outcome in Iraqi Patients on Clopidogrel After Percutaneous Coronary Intervention. Journal of cardiovascular pharmacology 2018 Mar . Mohammad Fic Ameen M, Al-Allawi Nasir |
| Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy. The pharmacogenomics journal 2018 Mar . Wu Yu, Zhou Yilun, Pan Yuesong, Zhao Xingquan, Liu Liping, Wang David, Wang Chunxue, Li Hao, Johnston S Claiborne, Meng Xia, Wang Yilong, Wang Yongjun, |
| Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes: The PHARMCLO Trial. Journal of the American College of Cardiology 2018 Feb . Notarangelo Francesca Maria, Maglietta Giuseppe, Bevilacqua Paola, Cereda Marco, Merlini Piera Angelica, Villani Giovanni Quinto, Moruzzi Paolo, Patrizi Giampiero, Tagliazucchi Guidantonio Malagoli, Crocamo Antonio, Guidorossi Angela, Pigazzani Filippo, Nicosia Elisa, Paoli Giorgia, Bianchessi Marco, Comelli Mario Angelo, Caminiti Caterina, Ardissino Die |
| The Prognostic Value of Combinations of Genetic Polymorphisms in the ITGB3, ITGA2, and CYP2C19*2 Genes in Predicting Cardiovascular Outcomes After Coronary Bypass Grafting. Genetic testing and molecular biomarkers 2018 Feb . Grinshtein Yuriy I, Kosinova Aleksandra A, Grinshtein Igor Y, Subbotina Tatyana N, Savchenko Andrey |
| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. JACC. Cardiovascular interventions 2018 01 11 (2): 181-191. Cavallari Larisa H, Lee Craig R, Beitelshees Amber L, Cooper-DeHoff Rhonda M, Duarte Julio D, Voora Deepak, Kimmel Stephen E, McDonough Caitrin W, Gong Yan, Dave Chintan V, Pratt Victoria M, Alestock Tameka D, Anderson R David, Alsip Jorge, Ardati Amer K, Brott Brigitta C, Brown Lawrence, Chumnumwat Supatat, Clare-Salzler Michael J, Coons James C, Denny Joshua C, Dillon Chrisly, Elsey Amanda R, Hamadeh Issam S, Harada Shuko, Hillegass William B, Hines Lindsay, Horenstein Richard B, Howell Lucius A, Jeng Linda J B, Kelemen Mark D, Lee Yee Ming, Magvanjav Oyunbileg, Montasser May, Nelson David R, Nutescu Edith A, Nwaba Devon C, Pakyz Ruth E, Palmer Kathleen, Peterson Josh F, Pollin Toni I, Quinn Alison H, Robinson Shawn W, Schub Jamie, Skaar Todd C, Smith D Max, Sriramoju Vindhya B, Starostik Petr, Stys Tomasz P, Stevenson James M, Varunok Nicholas, Vesely Mark R, Wake Dyson T, Weck Karen E, Weitzel Kristin W, Wilke Russell A, Willig James, Zhao Richard Y, Kreutz Rolf P, Stouffer George A, Empey Philip E, Limdi Nita A, Shuldiner Alan R, Winterstein Almut G, Johnson Julie A, |
| Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel. European journal of clinical pharmacology 2017 Dec . Mirjana Novkovic, Dragan Matic, Jelena Kusic-Tisma, Nebojsa Antonijevic, Dragica Radojkovic, Ljiljana Rakicev |
| [Impact of CYP2C19 genotype and platelet function on clinical outcome in coronary atherosclerotic heart diseases patients received clopidogrel post percutaneous coronary intervention]. Zhonghua xin xue guan bing za zhi 2017 May 45 (5): 377-385. Wu Y, Zhang X X, Tian L, Jiang J J, Xu L, Huang Y L, Liu H, Li Y |
| Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea. Gut and liver 2017 Apr . Choi Yoon Jin, Kim Nayoung, Jang In-Jin, Cho Joo-Youn, Nam Ryoung Hee, Park Ji Hyun, Jo Hyun Jin, Yoon Hyuk, Shin Cheol Min, Park Young Soo, Lee Dong Ho, Jung Hyun Ch |
| [Impact of CYP2C19 genotypes on antiplatelet therapy among Chinese patients with acute myocardial infarction after percutaneous coronary intervention]. Zhonghua xin xue guan bing za zhi 2017 Feb 45 (2): 116-120. Xu J J, Tang X F, Song Y, Xu N, Yao Y, Wu Y, Zhang J, Gao Z, Chen J, Gao R L, Yang Y J, Yuan J |
| Angiotensin-Converting Enzyme Inhibitors' Influence on Antiplatelet Therapy of Clopidogrel in ACS. Clinical laboratory 2016 Oct 62 (10): 1911-1918. Yang Shuo, Cui Chanjuan, Zhang Jie, Qiao R |
| Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors. American journal of therapeutics 0 25 (2): e202-e212. Tomek Aleš, Mat?oška Václav, Frýdmanová Alena, Magerová Hana, Šrámek Martin, Paulasova-Schwabová Jaroslava, R?ži?ková Tereza, Janský Petr, Šarbochová Ivana, Hada?ová Ivana, Kaplan Vojt?ch, Lacinová Zuzana, Táborský Lud?k, Serebruany Vict |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: